Observational Study of Innate Immunity in Allergic Asthma
This observational study is looking at how your body's natural defenses (innate immunity) might be different in healthy people, those with allergies, and those with asthma. Researchers are trying to find a "type 2 signature" – a pattern of cell changes – that could be linked to allergies or asthma. They will do this by studying cells in the lab and comparing them to samples from people. The goal is to see if this signature can help us understand these conditions better. You might be able to join if you are at least 18 years old and are healthy, have allergies, or have asthma. The study is currently unclear on its recruitment status.
- Study design
- This is an observational study planning to include 100 participants. It is not a treatment study, but rather aims to understand differences between groups.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint will be measured at 1 year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Innate Immunity in Allergic Asthma
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Justine T Tigno-Aranjuez, PhD · PRINCIPAL_INVESTIGATOR · University of Central Florida
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- To determine which parameters of the established type-2 signature obtained in vitro is significantly different between healthy controls, allergic individuals, and asthmatic individuals ex vivo.1 year